Akastor ASA (AKAST)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 12.96 |
|---|---|
| 52-week range | 10.60 – 16.12 |
| Return, 1 month / 3 months | +0.2% / +3.8% |
| Return, 1 year / 3 years | +42.0% / +48.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 27.5% |
| Worst drawdown (1 year) | -16.8% |
| Average daily value traded | 5.83M NOK |
| Dividend yield | 21.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Akastor is a Norwegian industrial investment company that owns and develops businesses serving the oil and gas industry and related sectors. Its portfolio companies supply equipment, services and technologies used in offshore and subsea oilfield operations, including drilling and well intervention equipment and engineering services. Customers are mainly energy companies and oilfield service providers operating in offshore markets, and the company is based in Norway, where it manages its holdings and supports the development of the businesses it owns.
On this site Akastor ASA appears as a stock on the Oslo Stock Exchange (Norway), code AKAST, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Akastor ASA (AKAST) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 12.96 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 78 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 42.0% and over the last three months it rose 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -18.5% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.8% | ||
| 6-month return | 3.0% | ||
| 12-month return, skipping the last month | 41.8% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.8% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.83M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 21.6% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | +0.2% |
| 3 months | +3.8% |
| 6 months | +3.0% |
| 1 year | +42.0% |
| 3 years | +48.0% |
| 5 years | +159.3% |
Signals
| 50-day / 200-day average | 13.26 / 12.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | NOK 0.5000 |
| 18 May 2026 | NOK 1.5000 |
| 16 Feb 2026 | NOK 0.4000 |
| 31 Oct 2025 | NOK 0.4000 |
| 14 Jul 2025 | NOK 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.